288 related articles for article (PubMed ID: 8118883)
1. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation.
Risdon G; Gaddy J; Stehman FB; Broxmeyer HE
Cell Immunol; 1994 Mar; 154(1):14-24. PubMed ID: 8118883
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic responses of human umbilical cord blood.
Risdon G; Gaddy J; Broxmeyer HE
Blood Cells; 1994; 20(2-3):566-70; discussion 571-2. PubMed ID: 7749122
[TBL] [Abstract][Full Text] [Related]
3. Immune responses by cord blood cells.
Roncarolo MG; Bigler M; Ciuti E; Martino S; Tovo PA
Blood Cells; 1994; 20(2-3):573-85; discussion 585-6. PubMed ID: 7749123
[TBL] [Abstract][Full Text] [Related]
4. IL-2-activated cord blood mononuclear cells.
Derzic S; Slone V; Sender L
Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
[TBL] [Abstract][Full Text] [Related]
5. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
Krampera M; Tavecchia L; Benedetti F; Nadali G; Pizzolo G
Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
7. Macrophage colony stimulating factor (M-CSF) within cord blood sera may be partially responsible for the reduced proliferation of cord blood T cells.
Cohen SB; Woolley J; Bogunia-Kubik K; Natarajan P; Kotecha R; Belaramani L; Fallen PR; Perez-Cruz I; Madrigal JA
Eur Cytokine Netw; 2000 Dec; 11(4):608-17. PubMed ID: 11125304
[TBL] [Abstract][Full Text] [Related]
8. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene.
Takahata Y; Nomura A; Takada H; Ohga S; Furuno K; Hikino S; Nakayama H; Sakaguchi S; Hara T
Exp Hematol; 2004 Jul; 32(7):622-9. PubMed ID: 15246158
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease.
Harris DT; LoCascio J; Besencon FJ
Bone Marrow Transplant; 1994 Oct; 14(4):545-53. PubMed ID: 7858529
[TBL] [Abstract][Full Text] [Related]
10. Immunological and functional differences between cord and peripheral blood.
Cohen SB; Madrigal JA
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S9-12. PubMed ID: 9712484
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of the cytotoxic alloresponse of cord blood.
Barbey C; Irion O; Helg C; Chapuis B; Grand C; Chizzolini C; Jeannet M; Roosnek E
Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S26-30. PubMed ID: 9715879
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells.
Keever CA; Abu-Hajir M; Graf W; McFadden P; Prichard P; O'Brien J; Flomenberg N
Bone Marrow Transplant; 1995 Mar; 15(3):407-19. PubMed ID: 7599566
[TBL] [Abstract][Full Text] [Related]
13. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells.
Chang CC; Satwani P; Oberfield N; Vlad G; Simpson LL; Cairo MS
Exp Hematol; 2005 Dec; 33(12):1508-20. PubMed ID: 16338494
[TBL] [Abstract][Full Text] [Related]
14. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells.
Chen L; Cohen AC; Lewis DB
Biol Blood Marrow Transplant; 2006 Feb; 12(2):160-71. PubMed ID: 16443514
[TBL] [Abstract][Full Text] [Related]
15. Differential cyclosporin-A sensitivity on survival and activation of umbilical cord and adult peripheral blood CD4+ T cells.
Lin SJ; Kuo ML; Cheng PJ; Hsiao SS
Transpl Immunol; 2007 Nov; 18(2):172-8. PubMed ID: 18005864
[TBL] [Abstract][Full Text] [Related]
16. Cord blood nucleated cells induce delayed T cell alloreactivity.
Chunduri S; Mahmud D; Abbasian J; Arpinati M; Rondelli D
Biol Blood Marrow Transplant; 2008 Aug; 14(8):872-9. PubMed ID: 18640570
[TBL] [Abstract][Full Text] [Related]
17. Cord blood transplantation: implications for graft vs. host disease and graft vs. leukemia.
Harris DT
Blood Cells; 1994; 20(2-3):560-4; discussion 564-5. PubMed ID: 7749121
[TBL] [Abstract][Full Text] [Related]
18. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
19. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells.
Lin SJ; Yan DC; Kuo ML; Cheng PJ; Hsiao SS; Tsai TL
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):586-92. PubMed ID: 16400900
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
